OBJECTIVE: To evaluate apraxia in healthy elderly and in patients diagnosed with Alzheimer's disease (AD) and Mild cognitive impairment (MCI). METHODS: We evaluated 136 subjects with an average age of
Detection performance measures for all methods (after ignoring incompatible combinations) as averages over 100 iterations are provided for multiple independent metadata design (MVA) with repeated meas
Participants with Post-COVID condition taking part in the Nautilus study (ClinicalTrials.gov ID: NCT05307575) and the Rehab COVID (ClinicalTrials.gov ID: NCT05846126) recruited by the Consorci Sanitar
